Granules India receives final approval for ADHD treatment drug from USFDA
The approved product is bioequivalent to the reference listed drug product (RLD), Ritalin LA extended-release capsules of Novartis Pharmaceuticals Corporation.
The approved product is bioequivalent to the reference listed drug product (RLD), Ritalin LA extended-release capsules of Novartis Pharmaceuticals Corporation. http://bit.ly/2HG251j May 26, 2019 at 07:53PM
The approved product is bioequivalent to the reference listed drug product (RLD), Ritalin LA extended-release capsules of Novartis Pharmaceuticals Corporation. http://bit.ly/2HG251j May 26, 2019 at 07:53PM
Comments
Post a Comment